Efficacy and Adverse Events of Transcatheter Arterial Chemoembolization in Combination With Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma
Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2015.554
Full Text
Open PDFAbstract
Available in full text
Date
April 24, 2015
Authors
Publisher
Spandidos Publications